← back to search
J. McKay
Wake Forest University
· US
Area of research
Nephrology · Hepatology
Research interest
Research interests include Medicine, Tolerability, Adverse effect, Internal medicine, and Urology.
h-index
—
citations
25
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Updated Safety and Efficacy Results of Abbv-383, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in a First-in-Human Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma
Blood
2023
cited by
25
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Katja Weisel
· National Institute Of Blood Disease and Bone Marrow Transplantation
1
papers (2023–2023)
Chetasi Talati
· AbbVie (United States)
1
papers (2023–2023)
Cesar Rodriguez Valdes
· Atrium Health Wake Forest Baptist
1
papers (2023–2023)
Ravi Vij
· Columbia University
1
papers (2023–2023)
Shaji Kumar
· Department of Internal Medicine
1
papers (2023–2023)
Anita D’Souza
· Medical College of Wisconsin
1
papers (2023–2023)
Sascha A. Tuchman
· University of North Carolina at Chapel Hill
1
papers (2023–2023)
—
·
1
papers (2023–2023)
Shane Lee
· Barwon Health
1
papers (2023–2023)
Tanya S Rosenberg
· AbbVie (United States)
1
papers (2023–2023)
Jeremy A. Ross
· AbbVie (United States)
1
papers (2023–2023)
Neha Korde
· Weill Cornell Medicine
1
papers (2023–2023)
Rajvineeth Kumar Pothacamury
· AbbVie (United States)
1
papers (2023–2023)
Peter M. Voorhees
· Atrium Health Wake Forest Baptist
1
papers (2023–2023)
Orlando F. Bueno
· AbbVie (United States)
1
papers (2023–2023)
Alfred Chung
· University of California, San Francisco
1
papers (2023–2023)
Ziyi Jin
· Jiangsu University
1
papers (2023–2023)
Akshanth R. Polepally
· University of Minnesota, Twin Cities
1
papers (2023–2023)
Aarif Ahsan
· New York University
1
papers (2023–2023)
Zhongling Feng
· AbbVie (United States)
1
papers (2023–2023)